home / stock / cwbr / cwbr news

CWBR News and Press, CohBar Inc. From 08/13/20

Stock Information
Company Name: CohBar Inc.
Stock Symbol: CWBR
Market: OTC
Website: cohbar.com
Menu
CWBR CWBR Quote CWBR Short CWBR News CWBR Articles CWBR Message Board
Get CWBR Alerts

News, Short Squeeze, Breakout and More Instantly...
CWBR - CohBar, Inc. (CWBR) CEO Steve Engle on Q2 2020 Results - Earnings Call Transcript

CohBar, Inc. (CWBR) Q2 2020 Earnings Conference Call August 13, 2020, 05:00 PM ET Company Participants Jordyn Tarazi - Director of IR Steve Engle - CEO Ken Cundy - Chief Scientific Officer Jeff Biunno - CFO Conference Call Participants Kumar Raja - Brookline Capital Marke...
CWBR - CohBar EPS misses by $0.03

CohBar (NASDAQ: CWBR ) : Q2 GAAP EPS of -$0.09 misses by $0.03 . More news on: CohBar, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...

CWBR - CohBar Reports Second Quarter 2020 Financial Results and Provides Business Update

New positive preliminary preclinical results in ARDS model Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., Aug. 13, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics t...

CWBR - Looking For Cheap Penny Stocks To Buy? 4 Trading Under $2 Right Now

4 Cheap Stocks To Watch This Week Penny stocks are definitely considered “affordable” but let’s not get than confused with “cheap”. When it comes to these small- and micro-cap companies, the price tag of the stock itself shouldn’t be the only thing y...
CWBR - CohBar Presents New Antifibrotic Data at the American Thoracic Society's Virtual 2020 Conference

MENLO PARK, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its ePoster featuring new antifibrotic data i...

CWBR - CohBar to Announce 2020 Second Quarter Financial Results and Provide Business Update on August 13, 2020

MENLO PARK, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that the company will release its second quarter 2...

CWBR - CohBar Resumes CB4211 Phase 1b Clinical Trial

MENLO PARK, Calif., July 07, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced that it has resumed the Phase 1b stage of its Phase 1a/...
CWBR - CohBar to Present at Sachs Novel Coronavirus Investment Forum

MENLO PARK, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, announced today that its Chief Executive Officer, Steven Engle, will pr...

CWBR - CohBar Added to Russell 2000® Index and Raises $4.4M in ATM Offering

MENLO PARK, Calif., June 30, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, was added to the US small-cap Russell 2000® Index during the 2020 ...

CWBR - CohBar Founder Dr. Nir Barzilai's New Book "AGE LATER" Reveals that Aging Can Be Seen as a Preventable Disease

MENLO PARK, Calif., June 17, 2020 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced the publication of “AGE LATER: Health Span, Life...
Previous 10 Next 10